88 related articles for article (PubMed ID: 8944056)
1. Interval carcinomas of the breast: a group with intermediate outcome.
Schroën AA; Wobbes T; van der Sluis RF
J Surg Oncol; 1996 Nov; 63(3):141-4. PubMed ID: 8944056
[TBL] [Abstract][Full Text] [Related]
2. Breast carcinoma diagnosis, treatment, and prognosis before and after the introduction of mass mammographic screening.
Ernst MF; Voogd AC; Coebergh JW; Roukema JA
Cancer; 2004 Apr; 100(7):1337-44. PubMed ID: 15042665
[TBL] [Abstract][Full Text] [Related]
3. Role of detection method in predicting breast cancer survival: analysis of randomized screening trials.
Shen Y; Yang Y; Inoue LY; Munsell MF; Miller AB; Berry DA
J Natl Cancer Inst; 2005 Aug; 97(16):1195-203. PubMed ID: 16106024
[TBL] [Abstract][Full Text] [Related]
4. Interval carcinomas in the Malmö Mammographic Screening Trial: radiographic appearance and prognostic considerations.
Ikeda DM; Andersson I; Wattsgård C; Janzon L; Linell F
AJR Am J Roentgenol; 1992 Aug; 159(2):287-94. PubMed ID: 1632342
[TBL] [Abstract][Full Text] [Related]
5. Infiltrating lobular carcinoma of the breast detected by screening.
Schroën AM; Wobbes T; van der Sluis RF
Br J Surg; 1998 Mar; 85(3):390-2. PubMed ID: 9529500
[TBL] [Abstract][Full Text] [Related]
6. A comparison of clinical-pathological characteristics between symptomatic and interval breast cancer.
Meshkat B; Prichard RS; Al-Hilli Z; Bass GA; Quinn C; O'Doherty A; Rothwell J; Geraghty J; Evoy D; McDermott EW
Breast; 2015 Jun; 24(3):278-82. PubMed ID: 25771080
[TBL] [Abstract][Full Text] [Related]
7. Comparison of clinical-pathologic characteristics and outcomes of true interval and screen-detected invasive breast cancer among participants of a Canadian breast screening program: a nested case-control study.
Rayson D; Payne JI; Abdolell M; Barnes PJ; MacIntosh RF; Foley T; Younis T; Burns A; Caines J
Clin Breast Cancer; 2011 Mar; 11(1):27-32. PubMed ID: 21421519
[TBL] [Abstract][Full Text] [Related]
8. The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization.
Bjurstam N; Björneld L; Duffy SW; Smith TC; Cahlin E; Eriksson O; Hafström LO; Lingaas H; Mattsson J; Persson S; Rudenstam CM; Säve-Söderbergh J
Cancer; 1997 Dec; 80(11):2091-9. PubMed ID: 9392331
[TBL] [Abstract][Full Text] [Related]
9. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
[TBL] [Abstract][Full Text] [Related]
10. Histopathology and growth rate of interval breast carcinoma. Characterization of different subgroups.
Brekelmans CT; van Gorp JM; Peeters PH; Collette HJ
Cancer; 1996 Sep; 78(6):1220-8. PubMed ID: 8826943
[TBL] [Abstract][Full Text] [Related]
11. Axillary node dissection in patients with breast cancer diagnosed through the Ontario Breast Screening Program: a need for minimally invasive techniques.
Singhal H; O'Malley FP; Tweedie E; Stitt L; Tonkin KS
Can J Surg; 1997 Oct; 40(5):377-82. PubMed ID: 9336528
[TBL] [Abstract][Full Text] [Related]
12. Risk for distant recurrence of breast cancer detected by mammography screening or other methods.
Joensuu H; Lehtimäki T; Holli K; Elomaa L; Turpeenniemi-Hujanen T; Kataja V; Anttila A; Lundin M; Isola J; Lundin J
JAMA; 2004 Sep; 292(9):1064-73. PubMed ID: 15339900
[TBL] [Abstract][Full Text] [Related]
13. Mammographic screening reduces risk of breast carcinoma recurrence.
Immonen-Räihä P; Kauhava L; Parvinen I; Holli K; Kronqvist P; Pylkkänen L; Helenius H; Kaljonen A; Räsänen O; Klemi PJ
Cancer; 2005 Feb; 103(3):474-82. PubMed ID: 15611974
[TBL] [Abstract][Full Text] [Related]
14. Molecular subtypes of breast cancers detected in mammography screening and outside of screening.
Sihto H; Lundin J; Lehtimäki T; Sarlomo-Rikala M; Bützow R; Holli K; Sailas L; Kataja V; Lundin M; Turpeenniemi-Hujanen T; Isola J; Heikkilä P; Joensuu H
Clin Cancer Res; 2008 Jul; 14(13):4103-10. PubMed ID: 18593987
[TBL] [Abstract][Full Text] [Related]
15. The comparative value of mammographic screening for women 40-49 years old versus women 50-64 years old.
Curpen BN; Sickles EA; Sollitto RA; Ominsky SH; Galvin HB; Frankel SD
AJR Am J Roentgenol; 1995 May; 164(5):1099-103. PubMed ID: 7717212
[TBL] [Abstract][Full Text] [Related]
16. Influence of mammographic parenchymal pattern in screening-detected and interval invasive breast cancers on pathologic features, mammographic features, and patient survival.
Porter GJ; Evans AJ; Cornford EJ; Burrell HC; James JJ; Lee AH; Chakrabarti J
AJR Am J Roentgenol; 2007 Mar; 188(3):676-83. PubMed ID: 17312053
[TBL] [Abstract][Full Text] [Related]
17. Screening mammography: value in women 35-39 years old.
Liberman L; Dershaw DD; Deutch BM; Thaler HT; Lippin BS
AJR Am J Roentgenol; 1993 Jul; 161(1):53-6. PubMed ID: 8517320
[TBL] [Abstract][Full Text] [Related]
18. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
Lynge E
APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
[TBL] [Abstract][Full Text] [Related]
19. Aggressiveness features and outcomes of true interval cancers: comparison between screen-detected and symptom-detected cancers.
Domingo L; Blanch J; Servitja S; Corominas JM; Murta-Nascimento C; Rueda A; Redondo M; Castells X; Sala M
Eur J Cancer Prev; 2013 Jan; 22(1):21-8. PubMed ID: 22584215
[TBL] [Abstract][Full Text] [Related]
20. Interval breast cancers in the Screening Mammography Program of British Columbia: analysis and classification.
Burhenne HJ; Burhenne LW; Goldberg F; Hislop TG; Worth AJ; Rebbeck PM; Kan L
AJR Am J Roentgenol; 1994 May; 162(5):1067-71; discussion 1072-5. PubMed ID: 8165983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
